Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | CRMD |
---|---|---|
09:32 ET | 4227 | 7.3 |
09:34 ET | 2468 | 7.27 |
09:36 ET | 1220 | 7.315 |
09:38 ET | 1100 | 7.31 |
09:39 ET | 1100 | 7.32 |
09:41 ET | 300 | 7.325 |
09:43 ET | 2009 | 7.35 |
09:45 ET | 367 | 7.34 |
09:48 ET | 100 | 7.34 |
09:50 ET | 100 | 7.35 |
09:52 ET | 2299 | 7.36 |
09:54 ET | 2581 | 7.32 |
09:56 ET | 569 | 7.2901 |
09:59 ET | 2667 | 7.35 |
10:01 ET | 1311 | 7.305 |
10:03 ET | 9372 | 7.3505 |
10:06 ET | 1200 | 7.31 |
10:08 ET | 3304 | 7.33 |
10:10 ET | 1417 | 7.39 |
10:12 ET | 1127 | 7.3824 |
10:14 ET | 800 | 7.37 |
10:15 ET | 503 | 7.35 |
10:17 ET | 595 | 7.331 |
10:19 ET | 100 | 7.35 |
10:21 ET | 300 | 7.33 |
10:24 ET | 4450 | 7.3108 |
10:26 ET | 1550 | 7.32 |
10:28 ET | 6700 | 7.32 |
10:30 ET | 1900 | 7.32 |
10:32 ET | 1100 | 7.335 |
10:33 ET | 2579 | 7.345 |
10:35 ET | 5695 | 7.37 |
10:37 ET | 1118 | 7.35 |
10:39 ET | 28790 | 7.345 |
10:42 ET | 900 | 7.33 |
10:44 ET | 600 | 7.34 |
10:46 ET | 8924 | 7.355 |
10:48 ET | 11168 | 7.422 |
10:50 ET | 720 | 7.42 |
10:51 ET | 1500 | 7.42 |
10:53 ET | 2737 | 7.42 |
10:55 ET | 900 | 7.42 |
10:57 ET | 200 | 7.43 |
11:00 ET | 2446 | 7.405 |
11:02 ET | 1640 | 7.41 |
11:04 ET | 1058 | 7.41 |
11:06 ET | 100 | 7.41 |
11:08 ET | 948 | 7.42 |
11:09 ET | 1390 | 7.42 |
11:11 ET | 6290 | 7.43 |
11:13 ET | 440 | 7.44 |
11:15 ET | 2638 | 7.44 |
11:18 ET | 16575 | 7.46 |
11:20 ET | 1050 | 7.459 |
11:22 ET | 4473 | 7.46 |
11:24 ET | 600 | 7.45 |
11:26 ET | 500 | 7.43 |
11:27 ET | 12180 | 7.43 |
11:29 ET | 700 | 7.41 |
11:31 ET | 953 | 7.42 |
11:33 ET | 250 | 7.4244 |
11:36 ET | 3800 | 7.43 |
11:38 ET | 400 | 7.44 |
11:40 ET | 1000 | 7.42 |
11:42 ET | 300 | 7.43 |
11:44 ET | 1500 | 7.41 |
11:45 ET | 500 | 7.4 |
11:47 ET | 5608 | 7.42 |
11:49 ET | 749 | 7.38 |
11:51 ET | 2009 | 7.39 |
11:54 ET | 400 | 7.39 |
11:56 ET | 2097 | 7.39 |
11:58 ET | 100 | 7.38 |
12:02 ET | 1200 | 7.37 |
12:03 ET | 2783 | 7.3736 |
12:05 ET | 700 | 7.3702 |
12:07 ET | 622 | 7.39 |
12:09 ET | 1296 | 7.37 |
12:12 ET | 2100 | 7.365 |
12:14 ET | 350 | 7.365 |
12:16 ET | 100 | 7.365 |
12:18 ET | 3263 | 7.34 |
12:20 ET | 6253 | 7.35 |
12:21 ET | 5257 | 7.355 |
12:23 ET | 300 | 7.355 |
12:25 ET | 308 | 7.34 |
12:27 ET | 9543 | 7.4 |
12:32 ET | 1300 | 7.415 |
12:36 ET | 300 | 7.415 |
12:38 ET | 1694 | 7.42 |
12:41 ET | 300 | 7.42 |
12:43 ET | 135 | 7.42 |
12:45 ET | 100 | 7.42 |
12:48 ET | 3273 | 7.42 |
12:50 ET | 773 | 7.42 |
12:54 ET | 300 | 7.42 |
12:56 ET | 1721 | 7.425 |
12:57 ET | 900 | 7.425 |
12:59 ET | 3041 | 7.435 |
01:01 ET | 2386 | 7.46 |
01:03 ET | 500 | 7.47 |
01:06 ET | 200 | 7.465 |
01:08 ET | 1000 | 7.465 |
01:10 ET | 1221 | 7.465 |
01:12 ET | 100 | 7.46 |
01:14 ET | 2613 | 7.465 |
01:15 ET | 600 | 7.47 |
01:17 ET | 300 | 7.46 |
01:19 ET | 1237 | 7.46 |
01:21 ET | 1883 | 7.465 |
01:24 ET | 200 | 7.46 |
01:26 ET | 2308 | 7.465 |
01:28 ET | 16969 | 7.48 |
01:30 ET | 5148 | 7.45 |
01:32 ET | 400 | 7.46 |
01:33 ET | 1200 | 7.465 |
01:35 ET | 900 | 7.48 |
01:37 ET | 640 | 7.485 |
01:39 ET | 500 | 7.485 |
01:42 ET | 16914 | 7.495 |
01:44 ET | 2400 | 7.5 |
01:46 ET | 1546 | 7.5003 |
01:48 ET | 200 | 7.5 |
01:50 ET | 1778 | 7.51 |
01:51 ET | 2000 | 7.515 |
01:53 ET | 1305 | 7.52 |
01:55 ET | 4680 | 7.545 |
01:57 ET | 1252 | 7.54 |
02:00 ET | 800 | 7.54 |
02:02 ET | 1250 | 7.505 |
02:04 ET | 934 | 7.505 |
02:06 ET | 1300 | 7.51 |
02:08 ET | 700 | 7.5163 |
02:09 ET | 1900 | 7.515 |
02:11 ET | 1211 | 7.515 |
02:13 ET | 2000 | 7.52 |
02:15 ET | 100 | 7.53 |
02:18 ET | 4388 | 7.53 |
02:20 ET | 3949 | 7.53 |
02:22 ET | 18389 | 7.575 |
02:24 ET | 2325 | 7.58 |
02:26 ET | 2622 | 7.58 |
02:27 ET | 1400 | 7.57 |
02:29 ET | 400 | 7.585 |
02:31 ET | 1830 | 7.58 |
02:33 ET | 786 | 7.58 |
02:36 ET | 500 | 7.595 |
02:38 ET | 1863 | 7.59 |
02:40 ET | 3161 | 7.56 |
02:42 ET | 59097 | 7.44 |
02:44 ET | 2406 | 7.469 |
02:45 ET | 300 | 7.45 |
02:47 ET | 1300 | 7.43 |
02:49 ET | 10706 | 7.455 |
02:51 ET | 100 | 7.445 |
02:54 ET | 2059 | 7.435 |
02:56 ET | 1613 | 7.407009 |
02:58 ET | 17429 | 7.37 |
03:00 ET | 5249 | 7.355 |
03:02 ET | 2126 | 7.35 |
03:03 ET | 1100 | 7.35 |
03:05 ET | 2199 | 7.35 |
03:07 ET | 1371 | 7.35 |
03:09 ET | 3478 | 7.375 |
03:12 ET | 1750 | 7.4 |
03:14 ET | 4412 | 7.41 |
03:16 ET | 5411 | 7.4299 |
03:18 ET | 3633 | 7.42 |
03:20 ET | 1593 | 7.43 |
03:21 ET | 7312 | 7.45 |
03:23 ET | 700 | 7.45 |
03:25 ET | 1636 | 7.44 |
03:27 ET | 3833 | 7.445 |
03:30 ET | 2198 | 7.455 |
03:32 ET | 1593 | 7.445 |
03:34 ET | 4695 | 7.47 |
03:36 ET | 4300 | 7.48 |
03:38 ET | 16419 | 7.505 |
03:39 ET | 433 | 7.505 |
03:41 ET | 22491 | 7.475 |
03:43 ET | 4726 | 7.47 |
03:45 ET | 3880 | 7.48 |
03:48 ET | 900 | 7.49 |
03:50 ET | 6833 | 7.505 |
03:52 ET | 9755 | 7.5 |
03:54 ET | 7170 | 7.505 |
03:56 ET | 8971 | 7.51 |
03:57 ET | 9292 | 7.505 |
03:59 ET | 78830 | 7.51 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
CorMedix Inc | 419.5M | -8.1x | --- |
Zevra Therapeutics Inc | 435.1M | -5.0x | --- |
Cipla Ltd | 15.8B | 0.0x | --- |
Elite Pharmaceuticals Inc | 404.4M | 19.8x | --- |
Calliditas Therapeutics AB | 1.2B | -22.6x | --- |
Incannex Healthcare Inc | 32.5M | 0.0x | --- |
CorMedix Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases. The Company is focused on commercializing its lead product DefenCath, which is an antimicrobial catheter lock solution approved to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter. DefenCath is a formulation of taurolidine 13.5 mg/mL, and heparin 1000 USP Units/mL indicated to reduce the incidence of catheter-related bloodstream infections (CRBSI) in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter (CVC). In addition to DefenCath, the Company has sponsored a pre-clinical research collaboration for the use of taurolidine as a possible treatment for rare pediatric tumors.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $419.5M |
---|---|
Revenue (TTM) | $806.1K |
Shares Outstanding | 55.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.60 |
EPS | $-0.93 |
Book Value | $1.28 |
P/E Ratio | -8.1x |
Price/Sales (TTM) | 520.4 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -7,212.46% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.